Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19

Autor: Samia Arshad, Paul Kilgore, Zohra S. Chaudhry, Gordon Jacobsen, Dee Dee Wang, Kylie Huitsing, Indira Brar, George J. Alangaden, Mayur S. Ramesh, John E. McKinnon, William O’Neill, Marcus Zervos, Varidhi Nauriyal, Asif Abdul Hamed, Owais Nadeem, Jennifer Swiderek, Amanda Godfrey, Jeffrey Jennings, Jayna Gardner-Gray, Adam M. Ackerman, Jonathan Lezotte, Joseph Ruhala, Raef Fadel, Amit Vahia, Smitha Gudipati, Tommy Parraga, Anita Shallal, Gina Maki, Zain Tariq, Geehan Suleyman, Nicholas Yared, Erica Herc, Johnathan Williams, Odaliz Abreu Lanfranco, Pallavi Bhargava, Katherine Reyes

Publikováno v: International Journal of Infectious Diseases, Vol 97, Iss , Pp 396-403 (2020)

Significance: The United States is in an acceleration phase of the COVID-19 pandemic. Currently there is no known effective therapy or vaccine for treatment of SARS-CoV-2, highlighting urgency around identifying effective therapies. Objective: The pu

Externí odkaz: https://doaj.org/article/f63e94b59bf1451cb9ceace2ebd92ec1

Characteristics and comparative clinical outcomes of prisoner versus non-prisoner populations hospitalized with COVID-19.

Autor: Altibi, Ahmed M.^1,2, Pallavi, Bhargava³, Liaqat, Hassan¹, Slota, Alexander A.¹, Sheth, Radhika¹, Al Jebbawi, Lama¹, George, Matthew E.⁴, LeDuc, Allison¹, Abdallah, Enas¹, Russell, Luke R.¹, Jain, Saniya⁵, Shirvanian, Nariné¹, Masri, Ahmad⁶, Kak, Vivek¹ Vkak1@hfhs.org

Publikováno v: Scientific Reports. 3/22/2021, Vol. 11 Issue 1, p1-9. 9p.

The role of tocilizumab therapy in critically ill patients with severe acute respiratory syndrome coronavirus 2

Autor: Weixia Guo, John E. McKinnon, Kylie Springer, Vivek Kak, Zaid Saffo, Kathleen Maksimowicz-McKinnon, Pallavi Bhargava

Publikováno v: Journal of Osteopathic Medicine. 121:705-714

Context Tocilizumab (TCZ), an interleukin-6 (IL-6) receptor antagonist, has been approved for use in rheumatoid arthritis and cytokine storm syndrome (CSS) associated with chimeric antigen receptor T cells treatment. Although TCZ is currently utilize

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bd57f654bc09512337b7a80150dfd4ef
https://doi.org/10.1515/jom-2020-0292

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19

Autor: Gordon Jacobsen, Owais Nadeem, Kylie Huitsing, Johnathan Williams, Indira Brar, Amit Vahia, Odaliz Abreu Lanfranco, Jayna Gardner-Gray, Nicholas Yared, Samia Arshad, William W. O'Neill, Amanda Godfrey, Joseph Ruhala, Mayur Ramesh, Jeffrey H. Jennings, Gina Maki, Erica Herc, John E. McKinnon, Tommy Parraga, Marcus J. Zervos, Zain Tariq, Pallavi Bhargava, Geehan Suleyman, Adam M. Ackerman, George Alangaden, Jennifer Swiderek, Smitha Gudipati, Varidhi Nauriyal, Zohra S Chaudhry, Jonathan Lezotte, Paul E. Kilgore, Asif Abdul Hamed, Dee Dee Wang, Anita Shallal, Raef Fadel, Katherine Reyes

Publikováno v: International Journal of Infectious Diseases, Vol 97, Iss, Pp 396-403 (2020)
International journal of infectious diseases, 97:P396-403
International Journal of Infectious Diseases

Significance The United States is in an acceleration phase of the COVID-19 pandemic. Currently there is no known effective therapy or vaccine for treatment of SARS-CoV-2, highlighting urgency around identifying effective therapies. Objective The purp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46f17ad5177a7e396dd492c86460efee
http://www.sciencedirect.com/science/article/pii/S1201971220305348

Rapid Reorganization of an Academic Infectious Diseases Program During the Coronavirus Disease 2019 Pandemic in Detroit: A Novel Unit-based Group Rounding Model

Autor: Geehan Suleyman, George Alangaden, Amit Vahia, Linda Kaljee, Zain Tariq, Odaliz Abreu-Lanfranco, Anne Chen, Tommy Parraga-Acosta, Nicholas Yared, Mayur Ramesh, Erica Herc, Smitha Gudipati, Zohra S Chaudhry, John E. McKinnon, Anita Shallal, Indira Brar, Jonathan Williams, Marcus J. Zervos, Pallavi Bhargava, Gina Maki, Varidhi Nauriyal

Publikováno v: Clinical Infectious Diseases

The surge of coronavirus disease 2019 (COVID-19) hospitalizations at our 877-bed quaternary care hospital in Detroit led to an emergent demand for Infectious Diseases (ID) consultations. The traditional 1-on-1 consultation model was untenable. Theref

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c61a84100e101fae7fa5dd84a397d41
https://doi.org/10.1093/cid/ciaa903